Bangladesh's pharmaceutical industry is a crucial provider of affordable medications domestically and to other Least Developed Countries (LDCs). The industry improves healthcare outcomes by ensuring access to essential medicines at low cost and contributes significantly to the country’s exports and economic growth.

Through digitalisation of the taxation system, Bangladesh could potentially achieve revenue mobilisation of up to USD 167 billion by 2030, marking a fourfold increase from the current fiscal year's amount.